Counselling women about periconceptional use of folic acid: The role of the community pharmacist can be improved

International Journal of Pharmacy Practice

Volumn 7, Issue 3, 1999, Pages 138-142

  De Jong Van Den Berg, L T W ^a,b   Van Der Zee, A H ^a   Schaafsma, E ^a   De Smit, D ^a   Anderson, C ^c   Cornel, M C ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Department of Social Pharmacy and Pharmacoepidemiology ^*  (Netherlands)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; ORAL CONTRACEPTIVE AGENT;

ARTICLE; ATTITUDE; CONCEPTION; DRUG INFORMATION; DRUG USE; GENERAL PRACTITIONER; HUMAN; NETHERLANDS; NEURAL TUBE DEFECT; PATIENT COUNSELING; PHARMACIST; PHYSICIAN ATTITUDE; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0032734729     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.1999.tb00960.x     Document Type: Article

References (16)

1. Den Ouden AL, Hirasing RA, Buitendijk SE, de Jong-van den Berg LTW, de Walle HEK, Cornel MC. Prevalentie, klinisch beeld en prognose van neurale buisdefecten in Nederland. Nederlands Tijdschrift voor Geneeskunde 1996;140:2092-5.
2. MRC vitamin study research group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991;338:131-7.
3. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
4. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-61.
5. Cornel MC, Erickson JD. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 1997;55:134-7.
6. Kessler DA. Communicating with patients about their medications. N Engl J Med 1991;325:1650-2.
7. Bradley CP, Taylor RJ, Blenkinsopp A. Developing prescribing in primary care. BMJ 1997;314:744-7.
8. Vries de CS. Collaboration in healthcare, the tango to drug safety [thesis]. RUG 1998. Wageningen. ISBN: 90-367-0978-4.
9. Geerts A. Campagne over foliumzuur gestart in September 1995. Voedingsmagazine 1995;8:3-5.
10. Brugman E, Van der Pal-de Bruin KM, Den Ouden AL, Drenthen AJM, Buitendijk SE. Gebruik van foliumzuur door vrouwen met kinderwens: de mening van de huisarts. Ned Tijdschr Geneeskd 1997;141:1653-7.
11. De Walle HEK, De Jong-van den Berg LTW, Cornel MC. Three years after the campaign folic acid use further increased in the Northern Netherlands. Lancet 1999;353:1187.
12. Bower C, Blum L, Ng ML, Irvin C, Kurinczuk J. Folate preventing neural tube defects. The pharmacist's contribution. Aust Pharm 1995;14:367-371.
13. Wild J, Schorah CJ, Maude K, Levene MI. Girls should be taught at school about importance of folic acid. BMJ 1996;312:974.
14. Dijkstra R. Computer-tailored interventions for smoking cessation: targeting smokers with low readiness to quit [thesis]. University of Maastricht 1998.
15. McKnight A. Alcohol consumption in pregnancy - a health education problem. J Roy Coll Pract 1987;37:73-6.
16. Fransens R, de Jong-van den Berg LTW, Cornel MC. De rol van de apotheker bij voorlichting over periconceptieel foliumzuurgebruik. Pharm Weekbl 1994;37:932.